Abstract
A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have